GSK2140944 capsule: Clinical Trials

2 trials of GSK2140944 capsule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow GSK2140944 capsule: new trials by email Literature Review of GSK2140944 capsule trials Research Report on GSK2140944 capsule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule - Infections, Bacterial
Phase 1CompletedGlaxoSmithKline462014-01-282017-07-13
A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
GSK2140944 for Injection, GSK2140944 Capsule - Infections, Respiratory Tract
Phase 1CompletedGlaxoSmithKline62013-11-082017-07-13

Conditions studied

Bacterial Infections (1)  ·  Respiratory Tract Infections (1)

Sponsors

GlaxoSmithKline (2)

Countries

United Kingdom (1)  ·  United States (1)

Results publications

PMID 35769034